Minh Cong Truong
9PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Nov 28, 2025
Real-World Effectiveness and Safety of Ribociclib Plus Aromatase Inhibitors in Patients with HR+/HER2- Metastatic Breast Cancer: A Multicenter Experience from Vietnam.Hoa Thi Nguyen, Quang Van Le, Huyen Thi Phung
|Oct 22, 2025
Real-World Evidence for First-Line afatinib in Advanced Non-Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations Other than G719X/L861Q/S768I.Thanh Ha Vu, Hoa Thai Thi Nguyen, To Van Ta
|Oct 21, 2025
Optimizing afatinib dosage: enhancing treatment outcomes and minimizing toxicities in advanced EGFR-mutated non-small cell lung cancer patients in Vietnam.Cam Phuong Pham, Hung Kien Do, Anh Tu Do
|May 25, 2025
Excellent survival benefit achieved in patients with advanced-stage non-small cell lung cancer harboring the epidermal growth factor receptor-G719X mutation treated by afatinib: the real-world data from a multicenter study in Vietnam.Van Luan Pham, Cam Phuong Pham, Thi Thai Hoa Nguyen
|Dec 18, 2024
The Effectiveness of Afatinib as First-Line Treatment in Vietnamese Patients With EGFR-Mutant Non-Small Cell Lung Cancer and Brain Metastases.Thai Van Pham, Thanh Ha Vu, Hoa Thai Thi Nguyen
|Oct 29, 2024
Efficacy and Tolerance of First-Line Afatinib in Elderly NSCLC Patients with EGFR Mutations in Vietnam: A Multicenter Real-World Study.Tu Anh Do, Hoa Thi Thai Nguyen, Phuong Cam Pham
Pageof 2
Frequent Collaborators
4 joint publications
Van Luan Pham
3 joint publications
Hung Kien Do
3 joint publications
Thanh Ha Vu
2 joint publications
Long Thanh Nguyen
1 joint publications
Cam Phuong Pham
1 joint publications
Dinh Thy Hao Vuong
1 joint publications
Van Thai Pham
1 joint publications
Hoang Gia Nguyen
1 joint publications
Van Tai Nguyen
1 joint publications
Hoa Thi Nguyen
